From: The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
Hazard ratio
95% CI
Standard Error
z
p value
Arterial hypertension
Yes
0.2025
0.1097 - 0.3739
0.0633
-5.11
0.000
Primary tumor
mutation Wild type
0.3292
0.1447 - 0.7491
0.1381
-2.65
0.008
PDGFRA mutation
1.8753
0.9096 - 3.8661
0.0692
1.70
0.049